Mimedx Group, Inc. (MDXG) Live Share Price, Invest From India

Mimedx Group, Inc. Stock Performance

as on November 1, 2025 at 1:29 am IST

Day's Low
Day's High
$7.28
Day's Price Range
$7.82
$7.64
4.71%
Downside
2.36%
Upside
52 Week's Low
52 Week's High
$5.79
52-Week Price Range
$10.14
$7.64
24.21%
Downside
32.72%
Upside

Mimedx Group, Inc. share price movements today

Previous Close: $7.40
Open: $7.28
Volume: 3.6M
Day's Low - High: $7.28 - $7.82
52 Week Low - High: $5.79 - $10.14

Mimedx Group, Inc. Historical Returns

1 Month Return: + 12.01 %
3 Month Return: + 6.84 %
1 Year Return: + 10.39 %
3 Year Return: + 153.31 %
5 Year Return: 0 %

Mimedx Group, Inc. Stock Fundamentals & Key Indicators

Check Mimedx Group, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1B

EPS (TTM)

0.4

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.50%

PE Ratio (TTM)

27.41

Industry PE ratio

-0.8126129032258065

PEG Ratio

2.97

EBITDA

53.7M

Revenue (TTM)

363.8M

Profit Margin

8.84%

Return On Equity TTM

16.61%

Mimedx Group, Inc. Stock Valuation

Track how Mimedx Group, Inc. P/E has moved over time to understand its valuation trends.

Mimedx Group, Inc. in the last 5 years

Overview
Trends

Lowest (-161.05x)

March 31, 2021

Industry (-0.81x)

November 1, 2025

Today (27.41x)

November 1, 2025

Highest (31.60x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 27.41x

Mimedx Group, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mimedx Group, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Mimedx Group, Inc.	BUY	$1.1B	NA	27.41	8.84%
Insmed Incorporated	BUY	$40.4B	475.59%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$59.4B	270.85%	-505.15	-12.96%
Vertex Pharmaceuticals Incorporated	BUY	$107.7B	104.25%	29.84	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$68.7B	19.91%	15.67	32.13%

Stock Returns calculator for Mimedx Group, Inc. Stock including INR - Dollar returns

The Mimedx Group, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Mimedx Group, Inc. investment value today

Current value as on today

₹1,15,951

Returns

₹15,951

(+15.95%)

Returns from Mimedx Group, Inc. Stock

₹10,245 (+10.25%)

Dollar Returns*

₹5,706 (+5.71%)

Analyst Recommendation on Mimedx Group, Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Mimedx Group, Inc.. Average target price of $12.2

Mimedx Group, Inc. Share Price Target

Get share price movements and forecasts by analysts on Mimedx Group, Inc..

What analysts predicted

37.38%UPSIDE

Target Price

$12.2

Current Price

$7.64

Analyzed by

11 Analysts

Target

$12.20

Mimedx Group, Inc. target price $12.2, a slight upside of 37.38% compared to current price of $7.64. According to 11 analysts rating.

Mimedx Group, Inc. Stock’s Investor Sentiment and Interest

Search interest for Mimedx Group, Inc. Stock has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Time period: October 4, 2025 to November 3, 2025

Change:43% versus previous 30 day period

Mimedx Group, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	81	81	86	84	87	84	92	88	98	113
Gross Profit	67	66	72	71	72	68	75	71	79	95
Operating Income	2	10	26	13	23	11	11	8	12	22
EBITDA	11	11	16	13	23	12	14	11	15	27
Interest Expense	1	1	1	1	0	0	2	0	0	0
Depreciation	0	0	0	0	1	1	2	3	3	-
Income Before Tax	1	9	25	11	23	11	11	8	13	22
Income Tax Expense	0	0	-37	2	5	3	3	1	3	6
Net Income	1	6	62	9	17	8	7	7	9	16
Net Profit Margin	1.48%	8.27%	72.19%	10.93%	20.21%	9.63%	8.01%	7.96%	9.75%	14.73%

Mimedx Group, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	187	245	321	359	359	248	242	267	321	348
Gross Profit	167	212	285	322	322	208	202	219	266	288
Operating Income	24	18	46	-3	-3	-44	-7	-14	37	58
EBITDA	27	23	53	2	2	-45	-1	-10	40	65
Interest Expense	0	0	-	-	-	7	4	5	6	1
Depreciation	-	-	5	6	7	6	5	4	3	6
Income Before Tax	24	18	45	-3	-3	-61	-12	-19	30	57
Income Tax Expense	-5	6	-19	26	26	-12	0	0	-36	15
Net Income	29	11	64	-29	-29	-49	-12	-30	67	42
Net Profit Margin	15.72%	4.89%	20.16%	-8.35%	-8.35%	-19.85%	-5.08%	-11.27%	20.98%	12.16%

Mimedx Group, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	8	62	9	17	7	7	7	9	16
Operating Cash Flow	12	10	4	21	19	18	5	14	29
Investing Cash Flow	0	0	-6	0	0	-2	0	0	-5
Financing Cash Flow	0	-8	-32	0	0	0	-2	-1	0
Change in Cash	12	0	-33	20	19	15	2	12	23

Mimedx Group, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	11	64	-29	-29	-25	-10	-30	67	41
Operating Cash Flow	25	62	35	35	-39	-1	-17	26	66
Investing Cash Flow	-11	-5	-9	-9	-4	-3	-2	-2	-9
Financing Cash Flow	-8	-60	-8	-8	62	-3	0	-8	-34
Change in Cash	5	-2	17	17	23	-8	-21	16	22

Global Institutional Holdings in Mimedx Group, Inc.

Funds	Holdings
Essex Woodlands Health Ventures	19.06%
BlackRock Inc	7.79%
Trigran Investments Inc	5.67%
Vanguard Group Inc	4.7%
Paradigm Capital Management, Inc.	3.01%

See all

Insights on Mimedx Group, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 7.02M → 16.74M (in $), with an average increase of 34.8% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 88.20M → 113.72M (in $), with an average increase of 11.9% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, MDXG stock has moved up by 9.5%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 184.3% return, outperforming this stock by 177.5%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 1009.8% return, outperforming this stock by 864.8%

About Mimedx Group, Inc.

mimedx® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. the company processes the human placental tissue utilizing its proprietary purion® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. mimedx has supplied more than two million allografts, through both direct and consignment shipments. for additional information, please visit www.mimedx.com.

Organisation	Mimedx Group, Inc.
Headquarters	1775 West Oak Commons Court, NE, Marietta, GA, United States, 30062
Industry	Biotechnology
CEO	Mr. Joseph H. Capper
E-voting on shares	Click here to vote

Key Management of Mimedx Group, Inc.

Name	Title
Mr. Joseph H. Capper	CEO & Director
Ms. Ricci S. Whitlow	Executive VP & COO
Mr. Matthew M. Notarianni	Head of Investor Relations
Mr. Mark P. Graves	Senior VP & Chief Compliance Officer
Ms. Hilary Dixon	Vice President of Investor Relations & Corporate Strategic Communications
Ms. Kate Surdez	Chief Human Resources Officer
Mr. Douglas C. Rice CPA	Chief Financial Officer
Mr. William F. Hulse IV	General Counsel & Chief Administrative Officer
Ms. Kimberly Maersk-Moller	Chief Commercial Officer
Dr. David H. Mason Jr., M.D.	Chief Medical Officer

FAQs

What is Mimedx Group, Inc. share price today?

Mimedx Group, Inc. share price today is $7.64 as on November 1, 2025 at 1:29 am IST at the close of the market. Mimedx Group, Inc. share today touched a day high of $7.82 and a low of $7.28.

What is the 52 week high and 52 week low for Mimedx Group, Inc. share?

Mimedx Group, Inc. share touched a 52 week high of $10.14 on December 10, 2024 and a 52 week low of $5.79 on June 20, 2025. Mimedx Group, Inc. stock price today i.e. November 1, 2025 at 1:29 am IST is closed at $7.64,which is 24.65% down from its 52 week high and 31.95% up from its 52 week low.

What is Mimedx Group, Inc.'s market capitalisation today?

Mimedx Group, Inc. market capitalisation is $0.00T as on November 1, 2025 at 1:29 am IST.

How to invest in Mimedx Group, Inc. Stock (MDXG) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Mimedx Group, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mimedx Group, Inc. Shares that will get you 0.1963 shares as per Mimedx Group, Inc. share price of $7.64 per share as on November 1, 2025 at 1:29 am IST.

What is the minimum amount required to buy Mimedx Group, Inc. Stock (MDXG) from India?

Indian investors can start investing in Mimedx Group, Inc. (MDXG) shares with as little as ₹88.719 or $1 (as of November 3, 2025 at 6:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹887.19 in Mimedx Group, Inc. stock (as per the Rupee-Dollar exchange rate as on November 3, 2025 at 6:38 am IST). Based on Mimedx Group, Inc. share’s latest price of $7.64 as on November 1, 2025 at 1:29 am IST, you will get 1.3089 shares of Mimedx Group, Inc.. Learn more about fractional shares .